Petros Grivas: Looking forward to a fantastic ESMO24

Petros Grivas shared a post on X by ESMO, adding:

“Looking forward to a fantastic ESMO24 with fantastic speakers, excellent content, collaboration, exchange, mentorship and networking!”

Quoting ESMO’s post:

“ESMO24: Last days to register. Join us for an extraordinary gathering of leading minds in oncology from around the globe.

Register today.”

Proceed to the video attached to the post.
Source: Petros Grivas/X and ESMO/X

Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance. He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018.

With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.

The European Society for Medical Oncology (ESMO) represents over 35,000 oncology professionals across 172 countries and is a key resource for oncology education and information. ESMO’s primary mission is to enhance the quality of cancer care, spanning prevention, diagnosis, palliative care, and patient follow-up.

It focuses on educating doctors, cancer patients, and the general public about best practices and the latest advancements in oncology, and advocates for equal access to optimal cancer care for all patients.